M&A Deal Summary |
|
---|---|
Date | 2013-09-04 |
Target | Canagen Pharmaceuticals - FerroHem |
Sector | Life Science |
Buyer(s) | Avricore Health |
Sellers(s) | Canagen Pharmaceuticals |
Deal Type | Divestiture |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 1996 |
Sector | Life Science |
Avricore Health is Western Canada’s first generic prescription and over-the-counter (OTC) product company. Vancpharm's primary mandate is to provide Canadians with affordable Generic Pharmaceuticals and OTC Health care products and consequently become one of the Canada’s leading suppliers of Generic Pharmaceuticals and OTC Health care products. Avricore Health was incorporated in 1996 and is headquartered in Vancouver, Canada.
DEAL STATS | # |
---|---|
Overall | 1 of 3 |
Sector (Life Science) | 1 of 2 |
Type (Divestiture) | 1 of 2 |
State (British Columbia) | 1 of 2 |
Country (Canada) | 1 of 3 |
Year (2013) | 1 of 1 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2016-12-05 |
HealthTab
Vancouver, British Columbia, Canada HealthTab, Inc. is a proven point-of-care solution provider to Canadian pharmacies. The HealthTab system requires just a few drops of blood from a finger prick and generates rapid, labaccurate results for up to 21 biomarkers, including lipids, glucose, liver function, kidney function and electrolytes. Patient results can be printed in-store and accessed securely through an online dashboard. HealthTab has been implemented in pharmacy banner and franchise locations throughout BC since 2014, including Pharmasave, Pure Integrative Pharmacy and The Medicine Shoppe. |
Buy | - |
Category | Company |
---|---|
Founded | 2001 |
Sector | Life Science |
Canagen Pharmaceuticals Inc. is an innovative and established Canadian generic pharmaceuticals manufacturer actively engaged in the manufacture of finished dosage generic pharmaceuticals, over-the counter (OTC) medication and active pharmaceutical ingredients (APIs) and in the research, development and commercialization of novel drugs covering the cardiovascular, oncology, dementia and anti-viral therapeutic areas.
DEAL STATS | # |
---|---|
Overall | 1 of 1 |
Sector (Life Science) | 1 of 1 |
Type (Divestiture) | 1 of 1 |
State (British Columbia) | 1 of 1 |
Country (Canada) | 1 of 1 |
Year (2013) | 1 of 1 |